Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,206,086 | 1,315,792 | 1,302,603 | 1,377,152 | 1,492,971 |
| Receivables | 84,841 | 82,465 | 115,756 | 174,877 | 171,070 |
| Inventories | 2,509 | N/A | 5,860 | 8,102 | 8,697 |
| TOTAL | $1,327,306 | $1,450,079 | $1,462,003 | $1,598,848 | $1,705,832 |
| Non-Current Assets | |||||
| PPE Net | 313,973 | 314,773 | 187,577 | 176,221 | 149,171 |
| Investments And Advances | 122,937 | 113,731 | 100,445 | 95,982 | 111,238 |
| Intangibles | 167,461 | 171,251 | 76,742 | 70,153 | 41,869 |
| Other Non-Current Assets | 485,532 | 489,487 | 43,928 | 53,015 | 49,616 |
| TOTAL | $1,089,903 | $1,089,242 | $408,692 | $395,371 | $351,894 |
| Total Assets | $2,417,209 | $2,539,321 | $1,870,695 | $1,994,219 | $2,057,726 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,571 | 10,451 | 11,323 | 19,459 | 35,257 |
| Accrued Expenses | 122,615 | 114,694 | 72,990 | 70,059 | 88,758 |
| TOTAL | $191,704 | $172,962 | $124,818 | $135,022 | $159,247 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 47,518 | 47,817 | 40,505 | 45,504 | 35,232 |
| Other Non-Current Liabilities | 443,104 | 452,925 | 74,661 | 65,146 | 69,772 |
| TOTAL | $617,919 | $630,082 | $306,141 | $292,141 | $284,431 |
| Total Liabilities | $809,623 | $803,044 | $430,959 | $427,163 | $443,678 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,137 | 48,815 | 43,500 | 37,421 | 37,216 |
| Common Shares | 194 | 190 | 165 | 164 | 162 |
| Retained earnings | -4,602,628 | -4,397,659 | -4,226,310 | -3,557,255 | -2,888,430 |
| Other shareholders' equity | -1,614 | -2,632 | -2,910 | 26,129 | 30,898 |
| TOTAL | $1,607,586 | $1,736,277 | $1,439,736 | $1,567,056 | $1,614,048 |
| Total Liabilities And Equity | $2,417,209 | $2,539,321 | $1,870,695 | $1,994,219 | $2,057,726 |